Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats

International Journal of Pharmaceutics

Volumn 440, Issue 2, 2013, Pages 154-160

  Balducci, Anna Giulia ^a   Ferraro, Luca ^a   Bortolotti, Fabrizio ^a   Nastruzzi, Claudio ^a   Colombo, Paolo ^b   Sonvico, Fabio ^b   Russo, Paola ^c   Colombo, Gaia ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Chimera agglomerate; Desmopressin; Microparticle; Nasal administration; Powder

Indexed keywords

ANTIDIURETIC AGENT; DESMOPRESSIN; MANNITOL; PHOSPHATIDYLCHOLINE; WATER;

ANIMAL EXPERIMENT; ARTICLE; CHIMERA; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MALE; NONHUMAN; NOSE; NOSE MUCOSA; PRIORITY JOURNAL; RAT; URINE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTIDIURETIC AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DEAMINO ARGININE VASOPRESSIN; MALE; NASAL MUCOSA; PARTICLE SIZE; POWDERS; RATS; RATS, WISTAR; RHEOLOGY; SOLUBILITY;

EID: 84872306629     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.09.049     Document Type: Article

References (24)

1. A.G. Balducci, G. Colombo, G. Corace, C. Cavallari, L. Rodriguez, F. Buttini, P. Colombo, and A. Rossi Layered lipid microcapsules for mesalazine delayed-release in children Int. J. Pharm. 421 2011 293 300
2. C. Bitter, K. Suter-Zimmermann, and C. Surber Nasal drug delivery in humans Curr. Probl. Dermatol. 40 2011 20 35
3. F. Bortolotti, A.G. Balducci, F. Sonvico, P. Russo, and G. Colombo In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate Eur. J. Pharm. Sci. 37 2009 36 42
4. J. Breitkreutz, and J. Boos Paediatric and geriatric drug delivery Expert Opin. Drug Deliv. 4 2007 37 45
5. R.L. Carr Evaluating flow properties of solids Chem. Eng. 72 1965 163 168
6. P. Chanson, and S. Salenave Treatment of neurogenic diabetes insipidus Ann. Endocrinol. (Paris) 72 2011 496 499
7. K.Y. Choi, Y.C. Kim, and M.G. Lee Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats Life Sci. 78 2006 1057 1062
8. European Medicines Agency (EMA)-Committee for Medicinal Products for Human Use (CHMP), 2006. Reflection Paper: Formulations of choice for the pediatric population. EMEA/CHMP/PEG/194810/2005.
9. European Medicines Agency (EMA)-Committee for Medicinal Products for Human Use (CHMP), 2006. Guideline on the pharmaceutical quality of inhalation and nasal products. EMEA/CHMP/QWP/49313/2005 Corr.
10. N. Fransén, S. Bredenberg, and E. Björk Clinical study shows improved absorption of desmopressin with novel formulation Pharm. Res. 26 2009 1618 1625
11. A.J. Hickey, and R.J. Garmise Dry powder nasal vaccines as an alternative to needle-based delivery Crit. Rev. Ther. Drug Carrier Syst. 26 2009 1 27
12. I. Jabbal-Gill Nasal vaccine innovation J. Drug Target. 18 2010 771 786
13. L.J. Jallo, C. Ghoroi, L. Gurumurthy, U. Patel, and R.N. Davé Improvement of flow and bulk density of pharmaceutical powders using surface modification Int. J. Pharm. 423 2012 213 225
14. K. Jonsson, K. Alfredsson, C. Soderberg-Ahlm, H. Critchley, A. Broeders, and M. Ohlin Evaluation of the degradation of desaminol,d-arginine8-vasopressin by nasal mucosa Acta Endocrinol. (Copenh.) 127 1992 27 32
15. F. Malerba, F. Paoletti, S. Capsoni, and A. Cattaneo Intranasal delivery of therapeutic proteins for neurological diseases Expert Opin. Drug Deliv. 8 2011 1277 1296
16. Y. Ozsoy, S. Gungor, and E. Cevher Nasal delivery of high molecular weight drugs Molecules 14 2009 3754 3779
17. Raffin, R.P., Colombo, P., Sonvico, F., Colombo, G., Rossi, A., Buttini, F., 2009. Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation. WO2009/052869 A1.
18. R.P. Raffin, P. Colombo, F. Sonvico, F.S. Polleto, G. Colombo, A. Rossi, A.R. Pohlmann, and S.S. Guterres Soft agglomerates of pantoprazole gastro-resistant microparticles for oral administration and intestinal release J. Drug Del. Sci. Tech. 17 2007 407 413
19. P. Russo, C. Sacchetti, I. Pasquali, R. Bettini, G. Massimo, P. Colombo, and A. Rossi Primary microparticles and agglomerates of morphine for nasal insufflation J. Pharm. Sci. 95 2006 2553 2561
20. P. Russo, F. Buttini, F. Sonvico, R. Bettini, G. Massimo, C. Sacchetti, P. Colombo, and P. Santi Chimeral agglomerates of microparticles for the administration of caffeine nasal powders J. Drug Del. Sci. Tech. 14 2004 449 454
21. C. Sacchetti, M. Artusi, P. Santi, and P. Colombo Caffeine microparticles for nasal administration obtained by spray drying Int. J. Pharm. 242 2002 335 339
22. J. Van de Walle, C. Van Herzeele, and A. Raes Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues Drug Saf. 33 2010 261 271
23. J. Vande Walle, M. Stockner, A. Raes, and J.P. Nørgaard Desmopressin 30 years in clinical use: a safety review Curr. Drug Saf. 2 2007 232 238
24. T.R. Wolfe, and D.A. Braude Intranasal medication delivery for children: a brief review and update Pediatrics 126 2010 532 537